Does PEMBROLIZUMAB Cause Hepatitis fulminant? 50 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 50 reports of Hepatitis fulminant have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.1% of all adverse event reports for PEMBROLIZUMAB.
50
Reports of Hepatitis fulminant with PEMBROLIZUMAB
0.1%
of all PEMBROLIZUMAB reports
36
Deaths
30
Hospitalizations
How Dangerous Is Hepatitis fulminant From PEMBROLIZUMAB?
Of the 50 reports, 36 (72.0%) resulted in death, 30 (60.0%) required hospitalization, and 9 (18.0%) were considered life-threatening.
Is Hepatitis fulminant Listed in the Official Label?
Yes, Hepatitis fulminant is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Hepatitis fulminant?
ACETAMINOPHEN (394)
NIVOLUMAB (60)
DEXAMETHASONE (59)
RITUXIMAB (51)
ATORVASTATIN (45)
IBUPROFEN (45)
PREDNISOLONE (45)
TRAMADOL (42)
AMIODARONE (40)
PANTOPRAZOLE (40)
Which PEMBROLIZUMAB Alternatives Have Lower Hepatitis fulminant Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G